Balance Labs (BLNC) Common Equity (2014 - 2026)

Balance Labs (BLNC) has reported Common Equity for 13 consecutive years, with -$2.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Common Equity rose 46.91% year-over-year to -$2.8 million; the trailing twelve-month figure through Jun 2026 stood at -$2.8 million (up 46.91% YoY), and the FY2025 full-year result was -$3.4 million, up 33.42% from the prior year.
• Common Equity rose to -$2.8 million in Q2 2026 per BLNC's latest filing, from -$2.9 million in the prior quarter.
• Across five years, Common Equity topped out at -$2.8 million in Q2 2026 and bottomed at -$8.7 million in Q3 2025.
• Historically, Common Equity has averaged -$4.5 million across 5 years, with a median of -$4.4 million in 2023.
• The sharpest annual moves came in 2022 and 2026: Common Equity slumped 2451.9% in 2022, then surged 46.91% in 2026.
• Over 5 years, Common Equity stood at -$4.2 million in 2022, then declined by 9.17% to -$4.5 million in 2023, then fell by 11.63% to -$5.1 million in 2024, then surged by 33.42% to -$3.4 million in 2025, then rose by 17.86% to -$2.8 million in 2026.
• According to Business Quant data, Common Equity over the past three periods registered -$2.8 million, -$2.9 million, and -$3.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.